Science Explorer Back to mapMap
Discussion
Company · Klosterneuburg · Austria

Polymun (Austria)

polymun.comROR OpenAlex
Research works
52
▼ 53% vs 2018-21
Citations
2.1k
41.3 per fractional work
Top-10% rate
16.8%
all institutions 10.0%
Open access
40%
world 40%
International
42%
world 18%
Polymun (Austria)

Not ranked overall: Polymun (Austria) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Polymun (Austria) work in?

In all years, 63% of research at Polymun (Austria) is in Life Sciences, 27% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (44%), Medicine (26%), Immunology and Microbiology (14%). It does 3.3× the world's share of Life Sciences.

Life Sciences: 33 fractional works · 63.0% of its workBiochemistry, Genetics and Molecular Biology: 23 fractional works · 43.6% of its workMolecular Biology: 16 fractional works · 30.5% of its workGenetics: 3 fractional works · 5.6% of its workBiotechnology: 2 fractional works · 4.6% of its workMolecular Medicine: 1 fractional works · 1.3% of its workCell Biology: 1 fractional works · 1.0% of its workBiophysics: 0 fractional works · 0.3% of its workImmunology and Microbiology: 7 fractional works · 13.7% of its workVirology: 4 fractional works · 6.8% of its workImmunology: 3 fractional works · 6.5% of its workMicrobiology: 0 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 2 fractional works · 4.2% of its workPharmaceutical Science: 2 fractional works · 4.2% of its workAgricultural and Biological Sciences: 1 fractional works · 1.3% of its workPlant Science: 1 fractional works · 1.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workNeuroscience: 0 fractional works · 0.3% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.3% of its workHealth Sciences: 14 fractional works · 26.6% of its workMedicine: 14 fractional works · 26.3% of its workRadiology, Nuclear Medicine and Imaging: 3 fractional works · 6.7% of its workInfectious Diseases: 2 fractional works · 4.3% of its workEpidemiology: 2 fractional works · 3.7% of its workPulmonary and Respiratory Medicine: 1 fractional works · 2.1% of its workOncology: 1 fractional works · 1.6% of its workHematology: 1 fractional works · 1.6% of its workEmergency Medicine: 1 fractional works · 1.2% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.8% of its workNeurology: 0 fractional works · 0.6% of its workNephrology: 0 fractional works · 0.6% of its workPathology and Forensic Medicine: 0 fractional works · 0.6% of its workPhysiology: 0 fractional works · 0.6% of its workPharmacology: 0 fractional works · 0.5% of its workGenetics: 0 fractional works · 0.3% of its workRehabilitation: 0 fractional works · 0.3% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.8% of its workNursing: 0 fractional works · 0.2% of its workNutrition and Dietetics: 0 fractional works · 0.2% of its workPhysical Sciences: 5 fractional works · 10.2% of its workMaterials Science: 2 fractional works · 4.0% of its workBiomaterials: 2 fractional works · 3.4% of its workSurfaces, Coatings and Films: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.3% of its workChemistry: 1 fractional works · 1.9% of its workSpectroscopy: 0 fractional works · 1.0% of its workOrganic Chemistry: 0 fractional works · 0.6% of its workAnalytical Chemistry: 0 fractional works · 0.3% of its workEngineering: 1 fractional works · 1.7% of its workBiomedical Engineering: 1 fractional works · 1.5% of its workElectrical and Electronic Engineering: 0 fractional works · 0.2% of its workPhysics and Astronomy: 0 fractional works · 1.0% of its workAtomic and Molecular Physics, and Optics: 0 fractional works · 1.0% of its workEnvironmental Science: 0 fractional works · 0.8% of its workEcology: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.3% of its workComputer Science: 0 fractional works · 0.4% of its workComputer Science Applications: 0 fractional works · 0.2% of its workHuman-Computer Interaction: 0 fractional works · 0.2% of its workChemical Engineering: 0 fractional works · 0.3% of its workBioengineering: 0 fractional works · 0.3% of its workSocial Sciences: 0 fractional works · 0.2% of its workPsychology: 0 fractional works · 0.2% of its workDevelopmental and Educational Psychology: 0 fractional works · 0.2% of its workALL ITS WORKPolymun (Austria)52fractional works, all years
Life Sciences63%Physical Sciences10%Health Sciences27%Social Sciences0%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 15 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology2343.6%
    2. Immunology and Microbiology713.7%
    3. Pharmacology, Toxicology and Pharmaceutics24.2%
    4. Agricultural and Biological Sciences11.3%
    5. Neuroscience00.3%
    1. Medicine1426.3%
    2. Nursing00.2%
    1. Materials Science24.0%
    2. Chemistry11.9%
    3. Engineering11.7%
    4. Physics and Astronomy01.0%
    5. Environmental Science00.8%
    6. Computer Science00.4%
    7. Chemical Engineering00.3%
    1. Psychology00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Polymun (Austria)?

Ranked on the quality score, Gabriela M. Stiegler, Brigitta A. Vcelar and Dietmar Katinger lead among researchers whose main affiliation is Polymun (Austria).

  1. 1 Gabriela M. Stiegler Austria · #171,069 worldwide 10k citations · 54 works
  2. 2 Brigitta A. Vcelar Austria · #985,165 worldwide 2.3k citations · 37 works
  3. 3 Dietmar Katinger Austria · #1,241,651 worldwide 1.3k citations · 31 works
  4. 4 Andreas Wagner Austria · #1,892,326 worldwide 1.2k citations · 30 works
  5. 5 Kornelia Schriebl Austria · #3,001,453 worldwide 647 citations · 15 works
All ranked researchers at Polymun (Austria)

What are the most cited papers from Polymun (Austria)?

The most cited paper from Polymun (Austria) is "Generation of glyco‐engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human‐like N‐glycan structure" (Richard Strasser, Johannes Stadlmann, Matthias Schähs et al., 2008), with 531 citations. Next come "Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies" (514) and "Liposome Technology for Industrial Purposes" (437).

Most cited papers
#PaperReleasedCitations
1 Generation of glyco‐engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human‐like N‐glycan structure Richard Strasser, Johannes Stadlmann, Matthias Schähs et al. · Plant Biotechnology Journal Open access 13 Mar 2008 531
2 Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies Alexandra Trkola, Herbert Kuster, Peter Rusert et al. · Nature Medicine 8 May 2005 514
3 Liposome Technology for Industrial Purposes Andreas Wagner, Karola Vorauer‐Uhl · Journal of Drug Delivery Open access 5 Dec 2010 437
4 Regulatory approval and a first‐in‐human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants Julian K‐C. et al. · Plant Biotechnology Journal Open access 3 Jul 2015 265
5 In Planta Protein Sialylation through Overexpression of the Respective Mammalian Pathway Alexandra Castilho, Richard Strasser, Johannes Stadlmann et al. · Journal of Biological Chemistry Open access 20 Mar 2010 231
All 61 most cited papers, with filters and sorting

Which keywords describe research at Polymun (Austria)?

By fractional works in all years, weighted toward what it does more of than the world: Glycosylation, Biopharmaceutical Production, Antiretroviral Therapy, Mammalian Cells, Recombinant Protein, Monoclonal Antibodies, Therapeutic Antibodies and Vaccine.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Glycosylation11▲ 95×3 topics
  2. Antiretroviral Therapy6▲ 49×4 topics
  3. Biopharmaceutical Production6▲ 147×2 topics
  4. Mammalian Cells6▲ 283×1 topic
  5. Recombinant Protein6▲ 283×1 topic
  6. Monoclonal Antibodies6▲ 75×3 topics
  7. Therapeutic Antibodies6▲ 83×2 topics
  8. Nanoparticles4▲ 6.4×10 topics
  9. Vaccine4▲ 20×5 topics
  10. Antibodies4▲ 91×2 topics
  11. Biopharmaceuticals4▲ 117×3 topics
  12. Immune Response4▲ 13×5 topics
  13. Recombinant Proteins4▲ 145×2 topics
  14. Gene Therapy4▲ 29×3 topics
  15. HIV4▲ 58×2 topics
  16. AIDS4▲ 130×1 topic
  17. Antibody Engineering4▲ 67×1 topic
  18. Fc Receptors4▲ 67×1 topic
  19. Immune Activation4▲ 74×1 topic
  20. Cancer3▲ 4.6×10 topics
  21. Drug Delivery3▲ 13×5 topics
  22. Genomic Integration3▲ 53×2 topics
  23. AAV3▲ 80×1 topic
  24. Viral Vectors3▲ 80×1 topic
  25. Cancer Therapy2▲ 7.4×3 topics
  26. Biomedical Applications2▲ 3.7×4 topics
  27. Immunogenicity2▲ 80×2 topics
  28. Plant Molecular Farming2▲ 157×1 topic
  29. Protein Aggregation2▲ 49×1 topic
  30. Stability2▲ 20×1 topic
  31. Vaccine Antigens2▲ 157×1 topic
  32. HIV Infection2▲ 28×2 topics
  33. Glycans2▲ 37×1 topic
  34. Immune System2▲ 9.7×2 topics
  35. Mucins2▲ 37×1 topic
  36. Lipid Rafts1▲ 38×1 topic
  37. Membrane Lipids1▲ 45×1 topic
  38. Nanocarriers1▲ 64×1 topic
  39. Surface Engineering1▲ 24×1 topic
  40. Drug Resistance1▲ 8.2×1 topic

Which research topics does Polymun (Austria) publish most on?

By volume in 2022-now: HIV Research and Treatment, Immunotherapy and Immune Responses, Monoclonal and Polyclonal Antibodies Research and Polymer crystallization and properties.

HIV Research and Treatment0HIV Research and Treatment: 0 fractional worksImmunotherapy and Immune…0Immunotherapy and Immune Responses: 0 fractional worksMonoclonal and Polyclona…0Monoclonal and Polyclonal Antibodies Research: 0 fractional worksPolymer crystallization …0Polymer crystallization and properties: 0 fractional worksHIV/AIDS drug development and treatment: 0 fractional worksGlycosylation and Glycoproteins Research: 0 fractional worksRNA Interference and Gen…0RNA Interference and Gene Delivery: 0 fractional worksEffects and risks of endocrine disrupting chemicals: 0 fractional worksHigh Altitude and Hypoxia: 0 fractional worksCardiovascular and Divin…0Cardiovascular and Diving-Related Complications: 0 fractional works
VirologyImmunologyRadiology, Nuclear Medicine and ImagingPolymers and Plastics5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 HIV Research and Treatment Virology 0 works
  2. 2 Immunotherapy and Immune Responses Immunology 0 works
  3. 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  4. 4 Polymer crystallization and properties Polymers and Plastics 0 works
  5. 5 HIV/AIDS drug development and treatment Infectious Diseases 0 works
  6. 6 Glycosylation and Glycoproteins Research Molecular Biology 0 works
  7. 7 RNA Interference and Gene Delivery Molecular Biology 0 works
  8. 8 Effects and risks of endocrine disrupting chemicals Health, Toxicology and Mutagenesis 0 works
  9. 9 High Altitude and Hypoxia Genetics 0 works
  10. 10 Cardiovascular and Diving-Related Complications Pulmonary and Respiratory Medicine 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available40.3%not open59.7%

World: 40% of research is openly available.

with international co-authors41.8%domestic only58.2%

World: 18% is written across borders.

How has Polymun (Austria)'s research output changed?

Output in 2022-2025 was 53% lower than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Polymun (Austria) as a percentage of every work published that year, 0.0000044% in 2023.

still counting0.00010%0.00020%0.00030%Polymun (Austria)0.000015% in 202520102020

Fractional works of Polymun (Austria) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Klosterneuburg

All research institutions in Klosterneuburg

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Polymun (Austria). Posts are plain text and can be reported.